Interestingly, enhanced sensitivity to treatment with CDDP, exhibited by OS and MCC cells exposed to different concentrations of small molecule NNMT inhibitors, was associated with increased ROS levels and apoptosis activation state. The gene discussed is NNMT; the disease is Merkel cell skin cancer.